Volume 32, Number 10—October 2026
Synopsis
Detection of Anaplasma capra in Patients with Suspected Crimean-Congo Hemorrhagic Fever, Turkey, 2022
Table 3
Laboratory testing results of patients diagnosed with anaplasmosis caused by Anaplasma capra, Turkey*
| Characteristic |
Patient 1 |
Patient 2 |
Patient 3 |
Patient 4 |
Patient 5 |
Patient 6 |
|---|---|---|---|---|---|---|
| Infectious agent | A. capra and CCHFV | A. capra | A. capra | A. capra and Brucella sp. | A. capra and CCHFV | A. capra |
| Laboratory testing (reference range) |
||||||
| Leukocytes, cells/mm3 (4,000–10,500) |
3,280 |
1,750 |
5,490 |
2,770 |
5,640 |
4,690 |
| Platelets, 103/mm3 (150–450) |
20 |
46 |
207 |
74 |
87 |
158 |
| Hemoglobin, g/dL (13.5–18.0 [M], 12.5–16.0 [F]) |
11.1 |
10.1 |
15.6 |
9.7 |
14.3 |
12.4 |
| AST, IU/L (0–40) |
1,549 |
78 |
28 |
219 |
362 |
27 |
| ALT, IU/L (0–40) |
476 |
103 |
29 |
95 |
216 |
20 |
| CPK, µg/mm3 (0–190) |
4,386 |
69 |
297 |
210 |
658 |
63 |
| LDH, IU/L (135–225) |
2,303 |
182 |
240 |
895 |
586 |
237 |
| PT, seconds (8.4–10.6) |
21.4 |
11.4 |
8.47 |
10.4 |
9.32 |
8.44 |
| aPTT, seconds (23.6–30.6) | 75.8 | 34.2 | 24.8 | 29.5 | 24.6 | 25 |
*ALT, alanine aminotransferase; aPTT, activated partial thromboplastin time; AST, aspartate aminotransferase; CCHFV, Crimean-Congo hemorrhagic fever virus; CPK, creatine phosphokinase; LDH, lactate dehydrogenase; PT, prothrombin time.
1These first authors contributed equally to this article.
Page created: August 05, 2026
Page updated: September 28, 2026
Page reviewed: September 28, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.